Gastrointestinal (GI): NSAIDs that block COX-one action have correlations with GI issues mainly because of the inhibition of your synthesis of gastroprotective brokers such as PGE2 and other prostaglandins. This inhibition causes diminished mucin manufacturing by gastric epithelial cells, much less bicarbonate secretion, and less epithelial cell turnover, among other https://johnv567tsr9.ssnblog.com/profile